Modular Proteoglycan Perlecan/HSPG2: Mutations, Phenotypes, and Functions.

Area of Science:

• Genetics and Molecular Biology
• Developmental Biology
• Biochemistry

Background:

• Heparan sulfate proteoglycan 2 (HSPG2) is a highly conserved gene vital for numerous developmental processes, including heart and brain formation.
• Its product, perlecan, maintains extracellular matrix integrity, regulates tissue boundaries, and influences cellular signaling pathways.
• HSPG2 is broadly expressed across the musculoskeletal system, highlighting its fundamental physiological role.

Purpose of the Study:

• To review and characterize known mutations and variants of the HSPG2 gene.
• To discuss the impact of these genomic modifications on perlecan expression, function, and resulting phenotypes.
• To correlate clinical findings with observed phenotypes resulting from HSPG2 mutations.

Main Methods:

• Literature review of studies on HSPG2 mutations and variants.
• Analysis of in vivo animal models and in vitro experimental systems.
• Synthesis of clinical data associated with reported HSPG2 mutations.

Main Results:

• Mutations in HSPG2 are rare, leading to a spectrum of phenotypes from mild to perinatally lethal.
• Genomic modifications affect perlecan's structural and signaling functions.
• Specific HSPG2 mutations are linked to distinct clinical presentations and pathologies.

Conclusions:

• Understanding HSPG2 mutations is key to comprehending perlecan's role in normal physiology and disease pathogenesis.
• Further mechanistic studies are warranted to elucidate the pathways affected by perlecan dysfunction.
• This review provides a foundation for future research into HSPG2-related disorders.